2023年5月15日

Autonomize AI -一个值得信赖的人工智能(AI)对卫生保健和生命科学公司——宣布关闭了一个400万美元的种子轮来支持公司的人工智能平台的开发和扩展。和资产管理公司领导,参与的ATX Venture Partners,循环投资,和下一个实践组。Autonomize AI会使用种子资金来提升其研发和商业化的努力。成立于2022年,Autonomize AI提供软件产品来降低成本和提高操作效率为卫生保健和生命科学组织。产品包括:- Autonomize像素,通过更高效的工作流和最优协议加速临床试验设计、可行性研究和患者匹配。- Autonomize向导,增加临床决策提供综合图表研究见解,付款人管理,注册中心和决策。-生成AI提供会话、搜索和总结能力安全内部数据来源,更符合实际的为不同的用户类型。Autonomize艾未未的解决方案是建立在一个安全的云计算平台优化的医疗行业,支持多模式数据类型和利用pre-trained医疗大型语言模型(llm)。这些llm可能调整私人数据和部署到虚拟私有云环境。加上Autonomize AI的隐私过滤器自动识别和匿名化个人身份信息和个人健康信息。 The company’s platform enables organizations to use AI capabilities without compromising patient data privacy and security. And by focusing on human-centered workflows, Autonomize AI is building the equivalent of the J.A.R.V.I.S. system (featured in Marvel’s Iron Man movies) for all healthcare workers to augment and empower their expertise. KEY QUOTES: “Despite the abundance of data and the availability of cutting-edge technology like AI, healthcare is broken for the patient. We are putting the patient back in the center of the healthcare ecosystem by empowering every knowledge worker with insights, content and context to do their best work and drive 100-times better patient outcomes. We are assembling some of the best scientists, researchers and engineers to solve this critical problem.” — Ganesh Padmanabhan, Autonomize AI founder and CEO “We believe that Autonomize AI holds the key to unlocking the vast potential of artificial intelligence in revolutionizing healthcare. While there is a lot of talk about AI in healthcare, extracting the insights buried within unstructured medical data in various silos is essential for fostering breakthroughs in patient care and overall health outcomes. We are thrilled to partner with this seasoned team, as they lead the charge in harnessing the power of AI to create a healthier future for all.” — Skip Fleshman, Asset Management Ventures General Partner “We evaluated several vendors building vertical solutions for patient matching and medical records review, but they offered limited solutions. Almost no existing platform consumes unstructured data and serves multiple contextual use cases. Autonomize AI has added tremendous value to SubjectWell in a short period of time by making our medical records review for clinical trials 10 times more efficient and accurate.” — Ivor Clarke, SubjectWell Chief Operating Officer Trending on Pulse 2.0